Cheerland Team
Cheerland’s international team of experts ensures the success of your projects.
Ruyin Liu
Founder of Cheerland Investment Group and Cheerland Biotechnology, Mr. Liu has over 20 years of experiences in capital investment and business operations… read more
Ruyin Liu
Founder and Chairman
Founder of Cheerland Investment Group and Cheerland Biotechnology, Mr. Liu has over 20 years of experiences in capital investment and business operations in China and abroad. He has established several successful companies in various industries in China and the US, and has successfully led many cross-border and cross-market transformations of the companies he founded. He has a Master’s degree in Business Operations from Nanyang Technological University, Singapore.
Weihua Ma
Renowned financier and entrepreneur, Dr. Ma is currently the chairman of the board of directors of the Shenzhen International Public Welfare Institute… read more
Dr. Weihua Ma
Co-Chair of the Board
Renowned financier and entrepreneur, Dr. Ma is currently the chairman of the board of directors of the Shenzhen International Public Welfare Institute, the executive director of the Chinese Finance Society, and the executive director of the Chinese Business Leaders’ Association. Former President of China Merchants Bank; Chairman of the National Science and Technology Achievement Transformation Guidance Fund, and other important positions. On Fortune’s “2012 China’s 50 Most Influential Business Leaders” list, Dr. Ma ranked 35th. He holds a Ph.D. in Economics from Southwestern University of Finance and Economics, and an Honorary Doctorate degree from the University of Southern California.
Daniel Brindle, JD
A visionary leader with over 25 years of experience in the global pharmaceutical industry… read more
Daniel Brindle, JD
Director of the BOD; CEO & CBO
A visionary leader with over 25 years of experience in the global pharmaceutical industry, Mr. Brindle was previously President of Novartis Group Greater China. Before that he was Attorney at Law and Partner at ZY Partners; Vice President, Government Affairs – Emerging Markets, Asia Pacific & Japan at GSK; Vice President, International Public Affairs & Policy – Asia Pacific at Pfizer. He also spent 12 years at Eli Lilly in various management positions including Vice President, Corporate Affairs, and Vice President, Business Development & Strategy – Asia. He holds a JD degree from Lewis & Clark Law School.
Cece Liu
Managing over a billion dollars of AUM for Cheerland’s overseas investment arm based in New York City, Ms. Liu led/participated in dozens of investment deals in both real estate and biotech in the past several years. She holds M.S. and B.S. degrees in Business Management from the University of Edinburgh, UK.
Kartik Padh
With over 20 years of international experience in the biopharma industry in Asia-Pacific, Europe and USA, Mr. Padh has held multiple… read more
Kartik Padh
Director of the BOD; President
With over 20 years of international experience in the biopharma industry in Asia-Pacific, Europe and USA, Mr. Padh has held multiple management and leadership positions in Quality and Compliance, Operations and Technology Transfer, Validation and Automation. He was previously Head of Quality / Head of Manufacturing at MSD Singapore; as Head of Manufacturing Quality at Samsung Biologics, helping to gain successful licensure of two DS and two DP facilities; and various technical and management positions in the industry including in Genentech.
Donald Palahnuk
With over 30 years of biotech experience, Mr. Palahnuk has demonstrated high-level leadership in process development… read more
Donald Palahnuk
Director of the BOD; CTO
With over 30 years of biotech experience, Mr. Palahnuk has demonstrated high-level leadership in process development, MST, technology transfer, and technical operations oversight. He founded and led MST or PD departments at Samsung Biologics, TopAlliance, ImClone/Eli Lilly, and Bio-Thera, where he managed TT and supported registration for ipilimumab, rituximab, nivolumab, and several other novel therapeutics. He also held engineering positions at global companies including Hoffmann-La Roche, Procter and Gamble, and Takeda. He has an M.S. in Chemical Engineering from Lehigh University.
John Zhang, PhD
With over 25 years of experience in both academia and the biotech industry, Dr. Zhang was previously Head & VP Biologics CMC at Zai Lab… read more
John Zhang, PhD
COO
With over 25 years of experience in both academia and the biotech industry, Dr. Zhang was previously Head & VP Biologics CMC at Zai Lab; VP Process Development & Manufacturing Technology at BeiGene; SVP Biopharmaceuticals and Director of Biopharmaceutical Research Institute at Qilu; Senior Researcher and Director of Biologics Process Validation Laboratory in MSAT, Lonza Biologics. He holds a PhD in Cellular and Molecular Biology from Eastern Virginia Medical School & Old Dominion University.
George Siu
With 20 years of biotech and pharmaceutical experience, Mr. Siu has held leading positions in QC Microbiology, Chemistry… read more
George Siu
VP Quality and Compliance
With 20 years of biotech and pharmaceutical experience, Mr. Siu has held leading positions in QC Microbiology, Chemistry, Equipment, Systems Validation, and Document Control at Baxter Biosciences, Amgen, and Samsung Biologics. He has also lead teams in Quality Digital Transformation and Data Integrity implementation. He has had a proven track record for the implementation of Lab Systems, such as LIMS, Electronic Lab Notebook, BMS, CDS, and equipment management systems.
Josh Walker
With 20 years of experiences in the biotech industry, Mr. Walker served as Senior Manager of Engineering at Samsung Biologics… read more
Josh Walker
VP Facilities Engineering
With 20 years of experiences in the biotech industry, Mr. Walker served as Senior Manager of Engineering at Samsung Biologics; Manufacturing Supervisor at Shire HGT; and over 10 years at Genentech at various capacities including Senior Supervisor of Manufacturing, Instrument and Electrical Sr. Supervisor (CCP2), and Instrumentation Supervisor (CCP1).
Mark Ramsey
Over 20 years of experience in the Biotech industry, working in areas of large-scale mammalian production (Amgen) to small batch process of vaccines… read more
Mark Ramsey
VP, CLB Shenzhen
Over 20 years of experience in the Biotech industry, working in areas of large-scale mammalian production (Amgen) to small batch process of vaccines (Novartis, Flu and Emergent BioSolutions, Anthrax). Most recently he has worked for KBI BioPharma, ThermoFisher Biotech, and Samsung Biologics. He has experience in Manufacturing (Upstream and Downstream), Quality (Investigations), Process Engineering, MSAT Technical Transfer (Upstream and Downstream), and Process Validation. Mark received his B.S. degree in Chemical Engineering from the University of Missouri at Columbia.
Yih Horng Tan, PhD
Dr. Tan has extensive experiences in running large domestic and international technology transfer projects in Drug Product Manufacturing… read more
Yih Horng Tan, PhD
VP Drug Product
Dr. Tan has extensive experiences in running large domestic and international technology transfer projects. He was previously Senior Manager of Drug Product Manufacturing Science and Technology at the BrammerBio part of Thermo Fisher Scientific; Senior Process Engineer at Lantheus Medical Imaging; Senior Research Scientist at Albany Molecular Research. He holds a B.S. in Chemistry from Acadia University, Ph.D. in Chemical Biology from University of California, Davis, and completed post-doctoral training at University of Missouri, St. Louis.
Tim Wu, PhD
With 26 years of experience in biologics development, Dr. Wu worked in the US at Boehringer Ingelheim, Pfizer… read more
Tim Wu, PhD
CSO & China BD Head
With 26 years of experience in biologics development, Dr. Wu worked in the US at Boehringer Ingelheim, Pfizer, Merck (MSD), Emory University, among others, where he directed & contributed as a core member for three antibody drugs approved & marketed in the US, Europe, and Japan. Since 2016 he has held drug development leadership positions in China at GSK, Janssen, Transcenta, China Resources Biopharma, among others. He holds BS & MS degrees in Medicine from Wuhan University, and PhD from University of Hong Kong.
Tim Calvert, PhD
Dr. Calvert has more than 15 years of experience in leading delivery of integrated drug discovery & development solutions … read more
Tim Calvert, PhD
VP International Markets
Dr. Calvert has more than 15 years of experience in leading delivery of integrated drug discovery & development solutions from virtual startups to global pharma, in both small and large molecule modalities. With a proven record of leadership and accomplishment, he was General Manager, Material and Structural Analysis at Thermo Fisher Scientific; VP at Abzena and Concept Life Sciences; Business Development Account Director at Catalent; and launched Lonza’s cell and gene therapy business in E.U. markets. He obtained his Ph.D. in Biotechnology from Glasgow Caledonian University.
Rick von Moos
Over 25 years dedicated to global GMP bio-manufacturing startups and operation experience; Lead Engineer at Samsung Biologics… read more
Rick von Moos
Sr. Director Facilities Engineering
Over 25 years dedicated to global GMP bio-manufacturing startups and operation experience. Previously he was Lead Engineer (Quality technology group) at Samsung Biologics; Sr. Supervisor of production maintenance at Genentech/ Roche drug product facility; Clean Utilities start up lead at a number of Genentech facilities (CCP1, CCP2) and Porrino Spain.
Harvey He, MBA
With over 25 years of experience in the pharma and biotech industry, Mr. He has held senior management positions … read more
Harvey He, MBA
Sr. Director Quality Operations
With over 25 years of experience in the pharma and biotech industry, Mr. He has held senior management positions in various companies such as Pharmaron Chemicals, WuXi Biologics, Fosun Pharma, Thermo Fisher Scientific and Albercon, in the US, Canada and China. Familiar with GMP regulations in China, Europe and the US, as well as quality systems. He holds a B.S. degree in microbiology from Shandong University and MBA from the University of Alabama.
Stephen Joshua Hee
With 20 years of experience in the biopharma industry, Mr. Hee has led various quality teams in Quality Control, Quality Validation… read more
Stephen Joshua Hee
Sr. Director QAS
With 20 years of experience in the biopharma industry, Mr. Hee has led various quality teams in Quality Control, Quality Validation, Quality Operations, External Quality, and Quality Systems to meet both quality and business requirements for companies like GSK Vaccine, Abbott, MSD Biotech, Lonza, Clover Biopharmaceuticals (Vaccine) and Thermofisher Scientific. He holds an Executive Master’s in Leadership, Strategy and Innovation, and a B.Sc degree in Biomedical Science and Molecular Biology from Murdoch University, AUS.
Fermin Valdon
With more than 15 years of pharmaceutical experience in cGMP manufacturing environment and 6 years at Samsung Biologics … read more
Fermin Valdon
Sr. Director Quality Engineering
With more than 15 years of pharmaceutical experience in cGMP manufacturing environment, Mr. Valdon previously spent 6 years at Samsung Biologics providing validation oversight in all aspects of New Product Introduction including cleaning validation, equipment qualification, process validation, exception and deviation investigations and change controls. He also supported preparation of Common Technical Document for health agency inspections for DS and DP marketing approvals for US, EU and rest of the world markets.
Yang Zhou
With more than 15 years of experience in quality and registration work in the pharmaceutical industry… read more
Yang Zhou
Sr. Director Registration
With more than 15 years of experience in quality and registration work in the pharmaceutical industry, Mr. Zhou has served as Director of Regulatory Affairs at Hepalink Pharmaceutical; Director of Global Business and Regulatory at GeneScience Pharmaceutical; Deputy GM of Regulatory Affairs at Fosun Pharma. He has led filing and marketing of multiple products, obtaining multiple IND, BLA, ANDA approvals from China, the United States, and the European Union.
Zhiyou Pan, PhD
With 10 years of experience in biopharmaceutical process development and technology transfer, Dr. Pan has served as Process Supervisor … read more
Zhiyou Pan, PhD
Director MSAT Upstream
With 10 years of experience in biopharmaceutical process development and technology transfer, Dr. Pan has served as Process Supervisor, Process Manager, and Deputy Director of R&D at Guangdong Temple Biochemical, Guangzhou Beixiu Biotech, Shenzhen Kexing Pharmaceutical, and Guangdong Hengda Pharmaceutical. He holds a PhD in Fermentation Engineering from South China University of Technology.
Yailen Rivero Barreiro
Over 18 years of experience in manufacturing of recombinant proteins for therapeutic use from mammalian cell culture … read more
Yailen Rivero Barreiro
Director Clinical Manufacturing
Over 18 years of experience in manufacturing of recombinant proteins for therapeutic use from mammalian cell culture, with leadership position in manufacturing. Experience in scale up, process analysis and validation of upstream and downstream process and Common Technical Document (CTD). Previously she was Production Director at Biotech Pharmaceutical (Beijing, P.R. China), and Director of Drug Substance Operations at the Molecular Immunology Center (Cuba).